Astellas Wins Additional Indications For Antifungal Mycamine
This article was originally published in The Pink Sheet Daily
Executive Summary
Injectable for Candida infections gets FDA okay for candidemia, acute disseminated candidiasis, candida peritonitis and abscesses.
You may also be interested in...
Astellas Tacrolimus Approval Remains At Bay
On heels of second “approvable” letter for kidney transplant rejection, FDA issues another approvable for liver indication.
Astellas Tacrolimus Approval Remains At Bay
On heels of second “approvable” letter for kidney transplant rejection, FDA issues another approvable for liver indication.
Astellas Seeks Mycamine Candidemia Claim With sNDA
Antifungal facing additional competition this year following approval of Pfizer, Schering-Plough products.